A study conducted at The Department of Urology, Yokosuka Kyosai Hospital, Japan, evaluated the efficacy and safety of using a low-dose chemotherapy combination of docetaxel, estramustine and dexamethasone in men with castrate resistant prostate cancer (CRPC). The study enrolled sixty-nine with CRPC. Docetaxel dosage was downed to 25 mg/m2 on days 1 and 8 every [...]
In June of 2009 a team at UCSF Department of Urology announced a new prostate cancer risk assessment test that they claim can provide men and their doctors a better way of gauging long-term risks and pinpointing high risk cases of prostate cancer. The test, as indicated by the researchers, proved accurate in predicting bone [...]
President Barack Obama has nominated Harold E. Varmus, M.D., the Nobel Prize-winning scientist for studies showing how certain normal genes could cause cancer when they went awry; to serve as the 14th director of the National Cancer Institute (NCI). Dr. Varmus served as director of the National Institutes of Health in the 1990s, a period [...]
Don Greggs, a long time prostate cancer survivor, recently asked his niece if people with cancer are able to donate organs at the time of their death. His niece who has worked in the organ recovery field gave him an answer that surprised me. She said that having cancer does not eliminate the possibility of [...]
We know that approximately one-third of all men who elect to have a radical prostatectomy for localized prostate cancer will ultimately experience a biochemical (PSA) recurrence. Researchers at the Department of Urology, Loyola University Medical Center, Maywood, IL, report on their long-term outcomes of salvage radiotherapy (SRT). […]
Many of us once considered drinking coffee nothing but a bad habit, but now it looks as if drinking coffee is actually a good thing for us. Researchers are finding more and more benefits from drinking coffee, from preventing cancer to fighting fatigue. […]
Dear President Obama, Prostate cancer will hit one in every six American men. This means that one in every six families will also be affected by prostate cancer. Prostate cancer is the second biggest cancer killer of American men. Sadly, many people don’t know that prostate cancer kills so many men. Prostate cancer is a [...]
Bavarian Nordic (B/N) is in the process of testing what might be the next prostate cancer vaccine to become available. They have successfully completed a phase II trial of 125 men with metastatic prostate cancer. The good news, the survival advantage experienced by the trial’s subjects had a statistically significantly longer median overall survival of [...]
Using a CTC-chip that measures the level of circulating tumor cells in blood can provide an important insight into the prognosis and potential rates of recurrent disease, according to data from a developing study at Massachusetts General Hospital, which was presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010. [...]
I have heard back that a number of people have contacted the call center at Dendreon (877-336-3736) and been told to call back at a later date for specific information about getting treatment. I have spoken with Dendreon and they have explained that they are working with the various infusion centers on mapping out specific [...]
